{
  "document": "Foundation_35",
  "Genomic Findings": [
    { "Name": "AKT2 amplification", "Clinical": [], "No Clinical": [] },    
    {
      "Name": "CCCNE1 amplification - equivocal",
      "Clinical": [],
      "No Clinical": []
    },
    { "Name": "CIC E1356*", "Clinical": [], "No Clinical": [] },
    { "Name": "MUTYH Q216*", "Clinical": [], "No Clinical": [] },
    { "Name": "RB1 R355fs*6", "Clinical": [], "No Clinical": [] },
    { "Name": "TP53 M246L", "Clinical": [], "No Clinical": [] }
  ],
  "Biomakers findings": [
    {
      "Name": "Blood Tumor Mutational Burden - 25 Muts/Mb",
      "Clinical": [
        "Atezolizumab",
        "Cemiplimab",
        "Durvalumab",
        "Nivolumab",
        "Pembrolizumab",
        "Dostarlimab"
      ],
      "No Clinical": ["Avelumab"]
    },
    {
      "Name": "Microsatellite status - MSI-High Not Detected",
      "Clinical": [],
      "No Clinical": []
    },
    { "Name": "Tumor Fraction - 21%", "Clinical": [], "No Clinical": [] }
  ]
}


